Takeda is teaming up with the Dutch testing firm Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status. Enzyre will receive ...

Hundreds of years after hemophilia was first discovered, a new medication that was successfully tested on a Fort Collins man could be an answer for those living with Hemophilia A. Andrew Schulz, a ...

A Philadelphia company's breakthrough treatment for hemophilia has passed a big test. Hemophilia is a condition where the blood doesn't clot like it's supposed to, so people can have severe bleeding ...

The best treatment for any disease, says Sigilon Therapeutics CEO Rogerio Vivaldi, M.D., is the body’s own cells. “If we allow cells to do what they are designed to do, that is the best treatment,” ...

Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its ...

Oct. 11 (UPI) --Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first once-weekly treatment for the disease. Hympavzi, made by ...

LONDON (Reuters) - Roche's new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical trials showed on Monday, setting it up to ...

The idea behind the at-home diagnostic kit is to provide patients with far greater control over the management their health. The kit is called the ENZYPAD and by using it a patient can painlessly take ...

rEVO Biologics of Framingham will begin late-stage trials of a drug intended to prevent and treat hemophilia A and B bleeding episodes in patients who have developed resistance to other treatments.

MedPage Today has been reporting on a variety of subjects relating to hemophilia A, from prevalence to treatment. Answer these questions to see how much you’ve retained. After taking the quiz, scroll ...

The management of hemophilia has come a long way, with researchers continuing to make strides against this disorder. Recently, Medscape asked hemophilia experts to weigh in on noteworthy news from the ...

This activity is free online at www.ajmc.com/ce and at www.arcmesa.org, where you will be directed to the activity including the online posttest, activity evaluation ...